Health & Medicine

First Protease Inhibitor Approved for HIV/AIDS

Saquinavir became the first protease inhibitor approved by the United States Food and Drug Administration to treat HIV/AIDS. This landmark approval marked a turning point in the management of the disease, offering new hope for patients. Within two years of its introduction, the efficacy of Saquinavir contributed to a significant reduction in annual AIDS-related deaths in the United States, decreasing from over 50,000 to approximately 18,000 due to improved treatment regimens.

Continue Reading